News & Stories
The stories of the Faculty of Arts and Sciences: the achievements and activities of our faculty, departments, and programs.
Search & Filter
-
Natarajan, Joseph S. and Sophia S. Fruton Professor of Astronomy and Professor of Physics, was recently interviewed by Amitabh Sinha of the Indian Express.
-
Jon Ellman, Eugene Higgins Professor of Chemistry, speaks to Yale's Department of Chemistry about his research on tert-butanesulfinamide and how ongoing advancements in synthetic chemistry facilitate drug discovery and contribute to life-saving treatments.
-
The new grants will build upon existing ISPS support for research that advances survey methodology, research exploring democratic innovations, as well as conferences addressing important social and public policy issues
-
FAS faculty member Damanveer Grewal conducts high-pressure experiments and analyzes meteorites to figure out how planets form—and where they obtain the ingredients that support life.
-
YCNCC News spoke with Planavsky, Professor of Earth and Planetary Sciences, about the need for “radical transparency” as the world works to scale carbon dioxide removal to massive levels—billions of tons per year—in order to meet climate goals.
-
In a Q&A, James Uden, Professor of Classics, discusses the “intense joy of life” in Roman culture, why Latin has so few poems about public bathing, and finding a good sake bar in New Haven.
-
Hailiang Wang, Professor of Chemistry, and his colleagues have developed a two-step method for converting carbon dioxide into carbohydrates that has potential applications in agriculture and biotech.
-
In a Q&A, cognitive neuroscientist Randolph Helfrich, Assistant Professor of Psychology, discusses the mystery of cognition, the interdisciplinary breadth of the neuroscience spectrum, and the lure of a San Francisco sourdough.
-
A new book from Kate Baldwin, Professor of Political Science, asks why African churches are increasingly advocating for liberal democracy.
-
Chemists at Yale, working with researchers from the US unit of Boehringer Ingelheim Pharmaceuticals in Connecticut, have developed an AI framework that generates experimental procedures for chemical synthesis, including for compounds that don’t currently exist.